CGM Experience, Preferences & Blood Glucose Parameters
Starting soon
Conditions studied: Diabete Mellitus, Type2diabetes, type1diabetes, Gestational Diabetes, Pre Diabetes
In brief
This is an open-label, prospective, multicenter observational study designed to evaluate the perceived benefits, device experience, preference, and glucose-related parameters associated with the Instara-1 Continuous Glucose Monitoring device. The study will include patients with diabetes and healthcare professionals. Patients will use Instara- 1 and will be followed up to assess device experience, glucose parameters, and diabetes-related quality of life. Healthcare professionals will evaluate device experience and preference, including comparison with FreeStyle Libre 2.
Key facts
- Study ID
- NCT07607015
- Run by
- Getz Pharma
- People needed
- 75
- Starts
- 2026-09-10
- Expected to finish
- 2027-08-10
- Last updated by the study team
- 2026-05-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects to provide written informed consent prior to any study procedures being performed
- Subjects with age 18 and above both male and female
- Diagnosed with Diabetes Miletus Type I, Type II and/or GDM
- Comfortable using smart phone, access to internet along with Bluetooth connectivity throughout the study duration.
- Subjects (Patients) on oral or injectable anti-diabetic medications, (in case of insulin, patient must be on insulin from last 3 months )
- Subjects (HCPs) healthy, Pre-diabetes or Diabetes Miletus (any type)
You may not qualify if…
- History of hypersensitivity to any of the active or inactive ingredients of the CGM device used in the trial, and/or history of significant allergic skin reactions.
- Presence of severe diabetes complications e.g. retinopathy, acute metabolic crisis, etc.
- History of active/ acute renal and/or hepatic failure.
- Patients who have been admitted to the hospital in the past 3 months for diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state.
- History of critical illness or incapacitated patients
- History of acute psychiatric disorder or exacerbation of chronic psychiatric disorder.
- History or presence of a medical condition or disease that in the investigator's opinion would embarrass glycemic control and completion of the study.
- Medical conditions that require patients to undergo frequent radiation/ imaging procedures for example CT, MRI and X rays
- History of known hematological disorders such as Sickle Cell Disease \& Trait, Thalassemia, Hemolytic Anemias (e.g., G6PD deficiency, autoimmune), Iron Deficiency Anemia
- Patients on high doses of acetaminophen (>1 gram every 6 hours), ascorbic acid supplements (e.g., > 500-1000 mg/day), IV sorbitol, steroids and aspirin which can alter the readings on the CGM device.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.